Abstract
Mosunetuzumab Shows Promising Efficacy in Patients with Multiply Relapsed Follicular Lymphoma: Updated Clinical Experience from a Phase I Dose-Escalation Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have